The report, authored by Modi’s chief economic adviser V Anantha Nageswaran, also urged India’s central and state governments to “get out of the way” and deregulate the economy or face a “high risk of ...

Out of the 41 analysts that have coverage on Sun Pharma, 30 of them have a 'Buy' rating on the stock. Seven of them have a ...

The stock market shall be looking at certain key factors including Capex, GDP growth, exports push that will drive Dalal ...

Ahead of the Budget, the BSE Sensex opened 136 points higher at 77,637 and the NSE Nifty belled the day at 23,528.60, up 22 ...

While Sun Pharma continues to demonstrate strength in its branded and specialty businesses, concerns around US generics, R&D ...

Emkay Global sees demand slump amid inflation across Nestle India's portfolio, as firming up of prices for coffee, cocoa and ...

The upcoming Union Budget 2024-25 is expected to focus on capital expenditure and macroeconomic stability, influencing market ...

Shares of GAIL (India) soared 7% in early trade on Friday post recording a 28% increase in consolidated net profit for the ...

Business Today’s coverage will analyse how the budget will impact markets, businesses, and taxpayers, beginning with ...

Finance Minister Nirmala Sitharaman is set to present the Union Budget for Fiscal 2025-26 on Saturday, February 1. It is one ...

GAIL reported the highest-ever nine-month PAT of Rs 9,263 crore for FY25, registering a massive growth of 39% amid high ...

Dabur's profit rose marginally, aligning with analysts' estimates. Net profit increased by 1.6% year-over-year to Rs 522 ...